Showing results (1791-1800 of 3,024) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|January 28, 2012
Regeneration of vessel wall functionality and vascular restoration therapy with biodegradable stents -- current statusRafal Depukat, Lukasz Rzeszutko, Dariusz DudekCurrent Pharmaceutical Biotechnology|January 28, 2012
Novel therapeutic approaches in limiting oxidative stress and inflammationAgnieszka Spychalowicz, Grzegorz Wilk, Tomasz Śliwa, et al.Current Pharmaceutical Biotechnology|January 28, 2012
Left ventricular hypertrophy in isolated aortic stenosis: primetime for the ventricleCristina Gavina, Inês Falcão-Pires, Francisco Rocha-Gonçalves, et al.Current Pharmaceutical Biotechnology|January 28, 2012
Cellular mechanisms for diastolic dysfunction in the human heartDániel Czuriga, Walter J Paulus, István Czuriga, et al.Current Pharmaceutical Biotechnology|February 21, 2012
Bacteria and their toxins tamed for immunotherapyIrena Adkins, Jana Holubova, Martina Kosova, et al.Current Pharmaceutical Biotechnology|February 21, 2012
Current immunotherapy of multiple sclerosis and future challenges: relevance of immune-mediated repairMichael D CarrithersCurrent Pharmaceutical Biotechnology|February 21, 2012
Infections in patients with rheumatic diseases treated with TNF antagonistsBeatriz Pérez-Zafrilla, Loreto Carmona, Juan J Gómez-ReinoCurrent Pharmaceutical Biotechnology|January 3, 2012
Autoantibodies and Sjögren's syndrome: a physiologist's perspectivePeter M Smith, Luke J DawsonCurrent Pharmaceutical Biotechnology|January 3, 2012
Primary Sjögren's syndrome and the type I interferon systemGunnel Nordmark, Maija-Leena Eloranta, Lars RonnblomCurrent Pharmaceutical Biotechnology|January 19, 2012
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic targetElisabetta Botti, Giulia Spallone, Roberta Caruso, et al.Pageof 303